Skip to content
10-Q

Quarterly Report

PetLife Pharmaceuticals, Inc.

0001493152-17-007933

← back to feed
Filed
Jul 18, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Jul 14, 2017 69.51M sh
Operating Cash Flow Q3 2017 · May 31, 2017 −$433.2K
Cash And Equivalents Q3 2017 · May 31, 2017 $321
Cash And Equivalents Q3 2017 · Aug 31, 2016 $1.17K
Stockholders Equity Q3 2017 · May 31, 2017 −$1.32M
Stockholders Equity Q3 2017 · Aug 31, 2016 −$3.23M
Current Liabilities Q3 2017 · May 31, 2017 $1.59M
Current Liabilities Q3 2017 · Aug 31, 2016 $3.24M
Total Liabilities Q3 2017 · May 31, 2017 $1.59M
Total Liabilities Q3 2017 · Aug 31, 2016 $3.24M
Current Assets Q3 2017 · May 31, 2017 $18.24K
Current Assets Q3 2017 · Aug 31, 2016 $1.17K
Total Assets Q3 2017 · May 31, 2017 $270.32K
Total Assets Q3 2017 · Aug 31, 2016 $1.17K
Net Income Q3 2017 · May 31, 2017 −$815.02K
Net Income Q3 2017 · May 31, 2017 −$21.26M
Net Income Q3 2017 · May 31, 2016 −$123.99K
Net Income Q3 2017 · May 31, 2016 −$364.63K
Operating Income Q3 2017 · May 31, 2017 −$571.98K
Operating Income Q3 2017 · May 31, 2017 −$20.94M
Operating Income Q3 2017 · May 31, 2016 −$123.99K
Operating Income Q3 2017 · May 31, 2016 −$364.63K